Abstract:OBJECTIVE:The bone marrow mesenchymal stem cells (BMSCs) have the capacity to differentiate into insulin-producing cells (IPCs) in vitro. However, low differentiation efficiency and poor maturity are the main obstacles. To investigate the feasibility of BMSCs differentiation into IPCs in diabetic pancreatic microenvironment of pigs. METHODS:BMSCs were isolated and purified from the bone marrow of a 4-week-old male pig. Fifteen female pigs (aged 8 to 10 weeks, weighing 8 to 10 kg) were randomly divided into 3 groups: normal control group (group A, n=5), diabetic control group (group B, n=5), and BMSCs transplanted group (group C, n=5). The pigs of groups B and C were treated by auris vein injections of streptozocin and alloxan for 3 days to induce diabetes mellitus (DM) model, whose blood glucose level 2 days all greater than 17 mmol/L was successful DM model. A total of 1.1 mL of the 3rd passage BMSCs labeled with enhanced green fluorescent protein (EGFP), with cell density of 5 x 10(7)/ mL, were injected into subcapsular pancreas of group C at multiple points, normal saline at the same dosage into those of groups A and B. After 30 days of monitoring blood glucose, the histological analysis of islet number and size were done; the immunofluorescence staining was used to detect the protein expression of insulin in the new-formed islets. The EGFP+ cells were collected from the sections using laser-capture microdissection; RT-PCR was used to detect insulin mRNA and pancreatic and duodenal homeobox factor 1 (PDX1) mRNA expressions from EGFP+ cells, and the insulin and sex determining region of the Y chromosome (SRY) genes were detected by fluorescence in situ hybridization (FISH). RESULTS:The blood glucose level decreased significantly in group C when compared with that in group B from 18 days and gradually decreased with time (P < 0.05). The histological observation showed that the number of islets was increased significantly in group C when compared with that in group B (10.9 +/- 2.2 vs. 4.6 +/- 1.4, P < 0.05), and there was no significant difference when compared with that in group A (10.9 +/- 2.2 vs.12.6 +/- 2.6, P > 0.05). The size of new-formed islets in group C was significantly smaller than that in group A [(47.2 +/- 19.6) microm vs. (119.6 +/- 27.7) microm, P < 0.05]. The immunofluorescence staining showed that new-formed islets of group C expressed insulin protein. RT-PCR showed that the microdissected EGFP+ cells of group C expressed insulin mRNA and PDX-1 mRNA. FISH showed that the new-formed islet cells of group C contained SRY gene in Y chromosome and insulin double positive cells. CONCLUSION:BMSCs can differentiate into IPCs in diabetic pancreatic microenvironment of pigs.

Circulation perfusion culture of insulin-producing cells using rat decellularized pancreatic scaffolds

3D perfusion culture of mouse insulinoma in macro-porous scaffolds enhanced insulin production response

Three-dimensional culture of MIN6 cells in decellularized pancreatic scaffold

[Differentiation of Bone Marrow Mesenchymal Stem Cells into Insulin Producing Cells Induced by Rat Injured Pancreatic Tissue Extract].

Comparative decellularization and recellularization of normal versus Streptozotocin-induced diabetes mellitus rat pancreas.

[Feasibility of Bone Marrow Mesenchymal Stem Cells Differentiation in Diabetic Pancreatic Microenvironment].

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells in Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia

Role of injured pancreatic extract promotes bone marrow-derived mesenchymal stem cells efficiently differentiate into insulin-producing cells.

Study of the Differentiation of Muscle-derived Stem Cells to Insulin-producing Cells Induced by Collagen Scaffold

Adhesive Growth of Pancreatic Islet Cells on a Polyglycolic Acid Fibrous Scaffold

Partially Repair Damaged Islets Of Diabetic Rat Model Via Insulin-Producing Cells Differentiated From Human Umbilical Cord Mesenchymal Stem Cells Infusion

The generation of islet-like insulin-producing cells from Wharton's jelly-derived mesenchymal stem cells on the PES/fish gelatin scaffold

Artificial pancreas composing of rat islets and swine small intestinal submucosa construction

Multipotent mesenchymal stromal cells derived from porcine exocrine pancreas improve insulin secretion from juvenile porcine islet cell clusters

IN VITRO TRANSDIFFERENTIATION OF RAT BONE MARROW MESENCHYMAL STEM CELLS INTO INSULIN-SECRETING CELLS

Evaluating the Biocompatibility of Decellularized Pancreas and Its Histological Features as a Support Structure for Adipose Mesenchymal Stem Cell Culture

Decellularized human pancreatic extracellular matrix-based physiomimetic microenvironment for human islet culture

The Effects of Transplantation of Bone Marrow Mesenchymal Stem Cells and Insulin Producing Cells from Them on Recipient Islets and Neovascularization

Establishment of decellularized extracellular matrix scaffold derived from caprine pancreas as a novel alternative template over porcine pancreatic scaffold for prospective biomedical application

Decellularized Whole-Organ Pre-vascularization: A Novel Approach for Organogenesis